| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 06/20/2002 | WO2001068851A3 Polypeptides and nucleic acids encoding same |
| 06/20/2002 | WO2001062298A3 Compositions and methods for treatment of angiogenesis in pathological lesions |
| 06/20/2002 | WO2001060857A3 Compositions useful for regulating parkin gene activity |
| 06/20/2002 | WO2001054652A8 A method of inducing autovaccination against hiv infection using structured treatment interruptions |
| 06/20/2002 | WO2001053487A3 Human sperm specific lysozyme-like proteins |
| 06/20/2002 | WO2001051633A3 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 06/20/2002 | WO2001044445A8 Human lyases and associated proteins |
| 06/20/2002 | WO2000075333A9 Streptavidin expressed gene fusions and methods of use thereof |
| 06/20/2002 | WO2000056774A9 Methods of using bioelastomers |
| 06/20/2002 | US20020077460 Ligand (ACT-4-L) to a receptor on the surface of activated CD4+ T-cells |
| 06/20/2002 | US20020077454 Therapeutic pore-forming peptides |
| 06/20/2002 | US20020077309 For diagnosis, prognosis, evaluation of therapies and treatment of pancreatic disorders |
| 06/20/2002 | US20020077305 Genetic immunization with cationic lipids |
| 06/20/2002 | US20020077295 For therapy of cranial or cerebral trauma, spinal cord injury, stroke or a demyelinating disease |
| 06/20/2002 | US20020077294 Method of treating blood disorders |
| 06/20/2002 | US20020077288 Synthetic immunogenic but non-amyloidogenic peptides homologous to amyloid beta for induction of an immune response to amyloid beta and amyloid deposits |
| 06/20/2002 | US20020077284 Inhibitors of HIV membrane fusion |
| 06/20/2002 | US20020077272 Contacting bacteria with an agent that alters the bacteria's native level of DNA methyltransferase (Dam) activity thereby altering the bacteria's native level of methylation of adenine in a GATC tetranucleotide of the bacteria |
| 06/20/2002 | US20020076813 Stabilizing diluent for polypeptides and antigens |
| 06/20/2002 | US20020076812 Generation of pluripotent cells; obtain cells, incubate with modulator, monitor gene expression in cells |
| 06/20/2002 | US20020076795 Novel TRF1 binding protein, methods of use thereof |
| 06/20/2002 | US20020076793 Interleukin-1 beta converting enzyme like apoptosis protease-3 and 4 |
| 06/20/2002 | US20020076766 Novel glucosaminidase |
| 06/20/2002 | US20020076721 Compositions and methods for the therapy and diagnosis of pancreatic cancer |
| 06/20/2002 | US20020076710 Detection and treatment of breast disease |
| 06/20/2002 | US20020076705 Nucleotide sequences which code preferential polypeptide; for use in the detection, treatment, and prevention of alzheimer's, parkinson's, huntington's, Tourette Syndrome, meningitis, encephalitis, congenital disorders and brain |
| 06/20/2002 | US20020076700 Nucleotide sequences coding secreted polypeptide; for use in treatment of cancer, autoimmune and skin disorders, allergies, infection, inflammation, arthritis, hematopoietic, atherosclerosis, restenosis and nervous system disorders |
| 06/20/2002 | US20020076695 Methods for treating prostate cancer |
| 06/20/2002 | US20020076691 Ribonucleic acid microorganism; for use in diangnosis and detection of viral diseases |
| 06/20/2002 | US20020076418 Use of strains of parapoxvirus ovis against organ fibrosis |
| 06/20/2002 | US20020076417 Mutated pathogenic bacteria strains; gene expression |
| 06/20/2002 | US20020076416 Chimeric peptide immunogens |
| 06/20/2002 | US20020076415 Hepatitis C virus gene products |
| 06/20/2002 | US20020076414 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use |
| 06/20/2002 | US20020076410 Administrating antigens for passive immunization against pathogens in dairy cows (and other milk producing mammals) |
| 06/20/2002 | US20020076409 Method for treating cancer |
| 06/20/2002 | US20020076408 Combination radiation therapy and chemotherapy in conjunction with administration of growth factor receptor antibody |
| 06/20/2002 | US20020076407 Method for selectively stimulating proliferation of t cells |
| 06/20/2002 | US20020076406 Multivalent target binding protein |
| 06/20/2002 | US20020076405 Antigenized antibody vaccine created from the grafting of peptide epitopes derived from foot-and-mouth disease virus into swine antibody complementarity determining region loops |
| 06/20/2002 | US20020076403 Recombinant protein containing a c-terminal fragment of plasmodium msp-1 |
| 06/20/2002 | US20020076392 Non-antibody immunomodulatory molecules such as cytokines expressed as membrane-bound fusion proteins; vaccines; immunotherapy |
| 06/20/2002 | CA2436830A1 Intracellular delivery of charged therapeutic moieties to nerve cells by means of targeting proteins |
| 06/20/2002 | CA2434915A1 Therapeutic agent comprising a b-subunit of a protein toxin |
| 06/20/2002 | CA2432736A1 Silenced anti-cd28 antibodies and use thereof |
| 06/20/2002 | CA2430972A1 Fibrin fragments for treating inflammation |
| 06/20/2002 | CA2430906A1 Proteins associated with cell growth, differentiation, and death |
| 06/20/2002 | CA2430896A1 Mhc class i associated peptides for prevention and treatment of tuberculosis |
| 06/20/2002 | CA2429755A1 Treatment and prevention of ebv infection and ebv-associated disorders |
| 06/20/2002 | CA2427271A1 Inflammatory markers for detection and prevention of diabetes mellitus |
| 06/20/2002 | CA2425513A1 Method of inhibiting infection by hcv, other flaviviridae viruses, and any other virus that complexes to low density lipoprotein or to very low density lipoprotein in blood preventing viral entry into a cell |
| 06/20/2002 | CA2365494A1 Lawsonia intracellularis vaccine |
| 06/19/2002 | EP1215497A1 Diagnostics for transmissible spongiform encephalopathy |
| 06/19/2002 | EP1215214A1 Novel polypeptide |
| 06/19/2002 | EP1214943A1 T-cell therapeutics for transmissible spongiform encephalopathy and method for the manufacture of non-infective blood products and tissue derived products |
| 06/19/2002 | EP1214942A2 Use of dendritic cells, loaded with bacteriophages which carry a tumour-specific and/or tumour-associated antigen on their surface, for treatment of tumours |
| 06/19/2002 | EP1214598A2 Screening for inhibitors of "paired helical filaments" |
| 06/19/2002 | EP1214595A2 Methods for diagnosis and therapy of hematological and virus-associated malignancies |
| 06/19/2002 | EP1214417A2 Nucleic acids and proteins from group b streptococcus |
| 06/19/2002 | EP1214416A2 Use of replication-deficient adenoviral vector to boost cd8+ t cell immune response to antigen |
| 06/19/2002 | EP1214410A1 Chimaeric plant viruses with mucin peptides |
| 06/19/2002 | EP1214398A2 Chimeric virus-like particles or chimeric capsomers from bpv |
| 06/19/2002 | EP1214342A1 Steroid hormone receptor polynucleotides, polypeptides, and antibodies |
| 06/19/2002 | EP1214341A1 Dendritic cell membrane protein fire |
| 06/19/2002 | EP1214340A2 Mutated anthrax toxin protective antigen proteins that specifically target cells containing high amounts of cell-surface metalloproteinases or plasminogen activator receptors |
| 06/19/2002 | EP1214339A2 Polypeptides from moraxella (branhamella) catarrhalis |
| 06/19/2002 | EP1214337A2 Proteins associated with cell differentiation |
| 06/19/2002 | EP1214333A2 Stabilized soluble glycoprotein trimers |
| 06/19/2002 | EP1214097A1 Nucleic acids encoding polyepitope polypeptides |
| 06/19/2002 | EP1214091A1 Therapies for chronic renal failure using one or more integrin antagonists |
| 06/19/2002 | EP1214090A2 Novel uses of mammalian ccr6 receptors and related reagents |
| 06/19/2002 | EP1214089A1 Therapeutic uses of m3 polypeptide |
| 06/19/2002 | EP1214088A1 Proteins expressed by mycobacterium tuberculosis and not by bcg and their use as diagnostic reagents and vaccines |
| 06/19/2002 | EP1214054A1 Intranasal influenza virus vaccine |
| 06/19/2002 | EP1214053A1 Adjuvant comprising a polyoxyethylene alkyl ether or ester and at least one nonionic surfactant |
| 06/19/2002 | EP0900275B1 Methods and reagents for modulating apoptosis |
| 06/19/2002 | EP0892643B1 Methods for inhibiting an immune response by blocking the gp39/cd40 and ctla4/cd28/b7 pathways and compositions for use therewith |
| 06/19/2002 | EP0714510B1 Natural killer cell-specific antigen and antibodies that identify the same |
| 06/19/2002 | EP0625204B1 Hepatitis therapeutics |
| 06/19/2002 | EP0611397B1 Feline leukemia virus vaccines |
| 06/19/2002 | EP0462215B1 MOLECULAR CLONING OF GENOMIC AND cDNA SEQUENCES ENCODING CELLULAR RECEPTORS FOR POLIOVIRUS |
| 06/19/2002 | CN1354800A Recombinant newcastle disease virus RNA expression systems and vaccines |
| 06/19/2002 | CN1354792A Biosynthesis of foreign proteins using transformed microalgae |
| 06/19/2002 | CN1354791A Compositions for treatment and diagnosis of breast cancer and methods for their use |
| 06/19/2002 | CN1354787A Process for purifying human papillomavirus virus-like particles |
| 06/19/2002 | CN1354675A Adjuvant combination formulations |
| 06/19/2002 | CN1354674A Synthetic peptide vaccines for foot-and-mouth disease |
| 06/19/2002 | CN1354671A Method for inhibition of phospholamban activity for treatment of cardiac disease and heart failure |
| 06/19/2002 | CN1354657A EGF-R antagonists for treating hypersecretion of mucus in lungs |
| 06/19/2002 | CN1354016A 双价活疫苗胶囊剂 Bivalent vaccine capsules |
| 06/19/2002 | CN1086421C Synthesis and clone of composite polyvalent vaccine gene for type-C hepatitis virus |
| 06/18/2002 | US6407306 Solvent extraction |
| 06/18/2002 | US6407214 Engineering human antibodies |
| 06/18/2002 | US6407213 Method for making humanized antibodies |
| 06/18/2002 | US6407063 Tumor antigens and CTL clones isolated by a novel procedure |
| 06/18/2002 | US6406911 Recombitant cells with reporter sequence for reporter gene and heterologous sequence which codes cd4 or other cell surface receptors regulated by a protein specific to hiv |
| 06/18/2002 | US6406900 Flea protease proteins, nucleic acid molecules and uses thereof |
| 06/18/2002 | US6406887 Antigens for binding to antibodies in tissues |
| 06/18/2002 | US6406885 Plant cell transformation vectors and dna code intimin |
| 06/18/2002 | US6406883 Lmb gene of Streptococcus agalactiae |